Compare ASMB & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASMB | PHUN |
|---|---|---|
| Founded | 2005 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 512.1M | 42.6M |
| IPO Year | 2010 | 2016 |
| Metric | ASMB | PHUN |
|---|---|---|
| Price | $19.68 | $1.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $52.00 | N/A |
| AVG Volume (30 Days) | ★ 195.8K | 67.6K |
| Earning Date | 11-09-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.78 | 39.36 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $30,883,000.00 |
| Revenue This Year | N/A | $37.21 |
| Revenue Next Year | N/A | $1,931.97 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 15.57 |
| 52 Week Low | $19.94 | $1.56 |
| 52 Week High | $39.71 | $2.84 |
| Indicator | ASMB | PHUN |
|---|---|---|
| Relative Strength Index (RSI) | 29.78 | 41.61 |
| Support Level | N/A | $1.62 |
| Resistance Level | $30.36 | $2.00 |
| Average True Range (ATR) | 1.13 | 0.06 |
| MACD | 0.10 | -0.01 |
| Stochastic Oscillator | 11.26 | 5.26 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services. Development services for customers who wish to have a customized application experience; and In-app advertising services for mobile audience building, user acquisition, application discovery, audience engagement and monetization.